Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,060 | 1,485 | 99.6% |
| Education | $91.40 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,661 | 162 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,941 | 105 | $0 (2024) |
| Lilly USA, LLC | $1,478 | 114 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,408 | 105 | $0 (2024) |
| PFIZER INC. | $1,220 | 99 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,218 | 117 | $0 (2024) |
| Amgen Inc. | $1,216 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,082 | 70 | $0 (2023) |
| Astellas Pharma US Inc | $1,024 | 54 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,004 | 77 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,603 | 145 | Bayer Healthcare Pharmaceuticals Inc. ($309.79) |
| 2023 | $2,861 | 163 | GlaxoSmithKline, LLC. ($306.18) |
| 2022 | $2,890 | 160 | Novo Nordisk Inc ($488.12) |
| 2021 | $3,124 | 184 | Novo Nordisk Inc ($544.76) |
| 2020 | $2,120 | 147 | Novo Nordisk Inc ($399.96) |
| 2019 | $3,234 | 237 | AstraZeneca Pharmaceuticals LP ($330.72) |
| 2018 | $2,908 | 207 | Amgen Inc. ($365.68) |
| 2017 | $3,412 | 250 | AstraZeneca Pharmaceuticals LP ($373.92) |
All Payment Transactions
1,493 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $19.22 | General |
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 3,631 | 5,983 | $673,737 | $173,171 |
| 2022 | 44 | 4,052 | 6,615 | $560,020 | $203,803 |
| 2021 | 39 | 3,899 | 6,404 | $546,259 | $204,743 |
| 2020 | 36 | 4,204 | 6,455 | $546,740 | $175,668 |
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 287 | 902 | $195,420 | $67,895 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 218 | 218 | $28,340 | $26,317 | 92.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 160 | $24,100 | $9,602 | 39.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 271 | 695 | $81,980 | $7,148 | 8.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 276 | 799 | $23,970 | $6,588 | 27.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 61 | 61 | $5,163 | $4,761 | 92.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 82 | 117 | $34,440 | $4,620 | 13.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 235 | 315 | $47,141 | $4,062 | 8.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 219 | 219 | $6,054 | $3,732 | 61.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 88 | 126 | $19,656 | $3,576 | 18.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 153 | 350 | $37,252 | $3,295 | 8.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 21 | $7,020 | $3,185 | 45.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $2,461 | $2,358 | 95.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 109 | 144 | $12,493 | $2,128 | 17.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,145 | $2,048 | 95.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 74 | 107 | $14,896 | $1,682 | 11.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 153 | 224 | $15,204 | $1,676 | 11.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 96 | 104 | $8,410 | $1,499 | 17.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,696 | $1,496 | 40.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 80 | 80 | $1,600 | $1,352 | 84.5% |
| 83735 | Magnesium level | Office | 2023 | 121 | 188 | $6,170 | $1,229 | 19.9% |
| 83721 | Ldl cholesterol level | Office | 2023 | 111 | 120 | $9,557 | $1,214 | 12.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 13 | 13 | $13,000 | $1,129 | 8.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 148 | 180 | $14,385 | $1,019 | 7.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 51 | 51 | $7,875 | $908.16 | 11.5% |
About Dr. Bruce Houston, D.O
Dr. Bruce Houston, D.O is a Family Medicine healthcare provider based in Albany, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285629907.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Houston, D.O has received a total of $23,151 in payments from pharmaceutical and medical device companies, with $2,603 received in 2024. These payments were reported across 1,493 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($23,060).
As a Medicare-enrolled provider, Houston has provided services to 15,786 Medicare beneficiaries, totaling 25,457 services with total Medicare billing of $757,385. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Albany, GA
- Active Since 09/19/2005
- Last Updated 01/23/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285629907
Products in Payments
- FARXIGA (Drug) $1,373
- Ozempic (Drug) $1,264
- TRELEGY ELLIPTA (Drug) $1,051
- XARELTO (Drug) $983.18
- ELIQUIS (Drug) $917.38
- JARDIANCE (Drug) $838.48
- Kerendia (Drug) $668.00
- TRULICITY (Drug) $602.57
- MYRBETRIQ (Drug) $560.30
- JANUVIA (Drug) $456.67
- Livalo (Drug) $438.07
- Dexcom G6 Transmitter (Medical Supply) $423.90
- ENTRESTO (Drug) $409.90
- Repatha (Biological) $400.07
- Aimovig (Biological) $387.03
- Rybelsus (Drug) $348.46
- GEMTESA (Drug) $344.08
- Saxenda (Drug) $337.22
- BELSOMRA (Drug) $306.40
- INGREZZA (Drug) $298.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Albany
Daniel Arenos, M.d, M.D
Family Medicine — Payments: $26,134
Mr. Michael Satchell, Md, MD
Family Medicine — Payments: $20,355
Theodore Hausler, D.o, D.O
Family Medicine — Payments: $16,979
Stephanie Williams, M.d, M.D
Family Medicine — Payments: $16,489
Mr. Derek Heard, Md, MD
Family Medicine — Payments: $15,696
Dr. Latifat Agbeja, M.d, M.D
Family Medicine — Payments: $14,194